These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 9788777)

  • 1. The actions of muscle relaxants at nicotinic acetylcholine receptor isoforms.
    Garland CM; Foreman RC; Chad JE; Holden-Dye L; Walker RJ
    Eur J Pharmacol; 1998 Sep; 357(1):83-92. PubMed ID: 9788777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potency of new muscle relaxants on recombinant muscle-type acetylcholine receptors.
    Paul M; Kindler CH; Fokt RM; Dresser MJ; Dipp NC; Yost CS
    Anesth Analg; 2002 Mar; 94(3):597-603; table of contents. PubMed ID: 11867382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isobolographic analysis of non-depolarising muscle relaxant interactions at their receptor site.
    Paul M; Kindler CH; Fokt RM; Dipp NC; Yost CS
    Eur J Pharmacol; 2002 Mar; 438(1-2):35-43. PubMed ID: 11906708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of amino acids and subunits in determining the inhibition of nicotinic acetylcholine receptors by competitive antagonists.
    Dilger JP; Vidal AM; Liu M; Mettewie C; Suzuki T; Pham A; Demazumder D
    Anesthesiology; 2007 Jun; 106(6):1186-95. PubMed ID: 17525594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characteristics of the inhibition of nondepolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine receptor.
    Jonsson Fagerlund M; Dabrowski M; Eriksson LI
    Anesthesiology; 2009 Jun; 110(6):1244-52. PubMed ID: 19417616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site selectivity of competitive antagonists for the mouse adult muscle nicotinic acetylcholine receptor.
    Liu M; Dilger JP
    Mol Pharmacol; 2009 Jan; 75(1):166-73. PubMed ID: 18842832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes.
    Zwart R; Vijverberg HP
    Mol Pharmacol; 1998 Dec; 54(6):1124-31. PubMed ID: 9855643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium.
    Kindler CH; Verotta D; Gray AT; Gropper MA; Yost CS
    Anesthesiology; 2000 Mar; 92(3):821-32. PubMed ID: 10719961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the interactions between volatile anesthetics and neuromuscular blockers at the muscle nicotinic acetylcholine receptor.
    Paul M; Fokt RM; Kindler CH; Dipp NC; Yost CS
    Anesth Analg; 2002 Aug; 95(2):362-7, table of contents. PubMed ID: 12145052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiemetics of the 5-hydroxytryptamine 3A antagonist class inhibit muscle nicotinic acetylcholine receptors.
    Paul M; Callahan R; Au J; Kindler CH; Yost CS
    Anesth Analg; 2005 Sep; 101(3):715-721. PubMed ID: 16115980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetics of inhibition of nicotinic acetylcholine receptors by (+)-tubocurarine and pancuronium.
    Wenningmann I; Dilger JP
    Mol Pharmacol; 2001 Oct; 60(4):790-6. PubMed ID: 11562442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct pharmacologic properties of neuromuscular blocking agents on human neuronal nicotinic acetylcholine receptors: a possible explanation for the train-of-four fade.
    Jonsson M; Gurley D; Dabrowski M; Larsson O; Johnson EC; Eriksson LI
    Anesthesiology; 2006 Sep; 105(3):521-33. PubMed ID: 16931985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual pharmacology of (+)-tubocurarine with rat neuronal nicotinic acetylcholine receptors containing beta 4 subunits.
    Cachelin AB; Rust G
    Mol Pharmacol; 1994 Dec; 46(6):1168-74. PubMed ID: 7808438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of local anesthetics on the inhibition of adult muscle-type nicotinic acetylcholine receptors by nondepolarizing muscle relaxants.
    Wang H; Zhang Y; Li ST
    Eur J Pharmacol; 2010 Mar; 630(1-3):29-33. PubMed ID: 20045405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic facilitatory adenosine A2A receptors mediate fade induced by neuromuscular relaxants that exhibit anticholinesterase activity.
    Bornia EC; Correia-de-Sá P; Alves-Do-Prado W
    Clin Exp Pharmacol Physiol; 2011 Mar; 38(3):164-9. PubMed ID: 21208254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of nondepolarizing neuromuscular blocking drugs to act as partial agonists at fetal and adult mouse muscle nicotinic receptors.
    Fletcher GH; Steinbach JH
    Mol Pharmacol; 1996 May; 49(5):938-47. PubMed ID: 8622644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of brain acetylcholine receptors by neuromuscular blocking drugs. A possible mechanism of neurotoxicity.
    Cardone C; Szenohradszky J; Yost S; Bickler PE
    Anesthesiology; 1994 May; 80(5):1155-61; discussion 29A. PubMed ID: 7912481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iontophoretic study of speed of action of various muscle relaxants.
    Min JC; Bekavac I; Glavinovic MI; Donati F; Bevan DR
    Anesthesiology; 1992 Aug; 77(2):351-6. PubMed ID: 1353667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors.
    Briggs CA; Gubbins EJ; Marks MJ; Putman CB; Thimmapaya R; Meyer MD; Surowy CS
    Mol Pharmacol; 2006 Jul; 70(1):227-40. PubMed ID: 16569710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open channel and competitive block of nicotinic receptors by pancuronium and atracurium.
    Löwenick CV; Krampfl K; Schneck H; Kochs E; Bufler J
    Eur J Pharmacol; 2001 Feb; 413(1):31-5. PubMed ID: 11173060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.